Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Eicosapentaenoic Acid and Valproic Acid

Research Papers that Mention the Interaction

DPA supplementation also significantly increased the proportions of EPA in TAG (by 3.1-fold, day 4) and cholesterol ester (CE) fractions (by 2.0-fold, day 7) and of DHA in TAG fraction (by 3.1-fold, day 4).
European Journal of Nutrition  •  2012  |  View Paper
EPA significantly increased platelet EPA (0.2±0.1 vs. 3.3±0.4%) and docosapentaenoic acid ( DPA ; 2.2±0.3 vs. 2.9±0.3%) concentrations, but not DHA.
Lipids  •  2006  |  View Paper
There was a positive association between age and EPA in PC, CE and TAG, DPA in NEFA and CE, and DHA in PC and CE (P≤0·034).
British Journal of Nutrition  •  2018  |  View Paper
At the conclusion of the study (day 9), it was found that liver DPA, EPA and total n-3 LC-PUFA levels were significantly increased by both DPA and EPA feeding compared with the olive oil fed control group.
Prostaglandins, leukotrienes, and essential fatty acids  •  2014  |  View Paper
Further, the retro-conversion of n-3 DPA led to a greater increase of EPA in the phospholipid fraction than in the neutral lipid fraction.
Journal of oleo science  •  2016  |  View Paper
The data open a new area of investigation, which is how EPA 's conversion to DPA substantially moderates its influence on membrane properties.
The Journal of nutrition  •  2016  |  View Paper
The addition of EPA to the diet resulted in a substantial increase in the efficiency of DPA retention; the inclusion of ARA had the opposite effect.
Fish Physiology and Biochemistry  •  2014  |  View Paper
Additionally, in a mouse PTZ convulsion model, EPA markedly augmented the anticonvulsant effects of VPA far beyond their single responses.
Because hepatotoxicity is a prominent adverse drug reaction, we currently attempted a new approach in which EPA was challenged to both alleviate hepatotoxicity and provide synergy with anticonvulsant effects of valproate (VPA).
Besides, we verified whether EPA may kinetically modulate the clearance rate of VPA.
Biochimica et biophysica acta  •  2011  |  View Paper
EPA (20:5n-3) … higher in the DPA group and most pronounced in the kidney (5.1 times higher in the TL as compared to controls) relative to liver … an estimated apparent % conversion of DPA to EPA of 67% and EPA:DPA ratios reaching 5.74 in kidney phosphatidylethanolamine.
Lipids  •  2011  |  View Paper
The effect of DPA was stronger than those of EPA and docosahexaenoic acid (22:6, n-3).
Prostaglandins, leukotrienes, and essential fatty acids  •  2003  |  View Paper
Show More